[ORGANIZATION]
Otsuka Pharmaceutical
Featured in 5 tracked stories · first seen
Situations
[ACTIVE]
[HEALTH]
IgA nephropathy clinical trial developments
2 clusters · 8 sources · last updated
Latest: Otsuka Pharmaceutical reports kidney function preservation in IgAN study
Recent clinical trial results have demonstrated progress in treating IgA nephropathy (IgAN) through different therapeutic approaches. In the phase 3 RAINIER trial, the investigational dual inhibitor povetacicept showed
Also covered in
-
Ionis and Otsuka report positive Phase 3 results for FUS-ALS treatment
[HEALTH] · 4 sources ·
-
Otsuka Pharmaceutical expands SOYJOY brand with new flavor
[BUSINESS] · 2 sources ·